TorMagnus Pharmaceuticals

San Francisco, United States

TorMagnus Pharmaceuticals is a drug discovery firm dedicated to discovering treatments for Peroxisomal disorders.

$500K raised

Apr 2023

Pre-Seed

Artificial Intelligence (AI)Biotechnology Simulation

Top Investors

Y Combinator

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TorMagnus Pharmaceuticals

How much funding has TorMagnus Pharmaceuticals raised?

TorMagnus Pharmaceuticals has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in April 2023.

Who are TorMagnus Pharmaceuticals's investors?

TorMagnus Pharmaceuticals's investors include Y Combinator.

Where is TorMagnus Pharmaceuticals headquartered?

TorMagnus Pharmaceuticals is headquartered in San Francisco, United States.

What does TorMagnus Pharmaceuticals do?

TorMagnus Pharmaceuticals is a drug discovery firm dedicated to discovering treatments for Peroxisomal disorders.

What stage is TorMagnus Pharmaceuticals at?

TorMagnus Pharmaceuticals is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 5, 2023.

MLA

"TorMagnus Pharmaceuticals — Funding & Investors." VCBacked, April 5, 2023, https://www.vcbacked.co/company/tormagnus-pharmaceuticals. Accessed July 2, 2026.

APA

VCBacked. (2023). TorMagnus Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/tormagnus-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=TorMagnus Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/tormagnus-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 5, 2023.